Latest On CVS Health Corporation (CVS):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2024-07-22 05:43 EST | Dividend | A dividend of $0.67 has been announced on Jul 8, 2024. It will be paid Aug 1, 2024 with an ex-dividend date of Jul 22, 2024. | Neutral |  |
| 2024-04-19 05:43 EST | Dividend | A dividend of $0.67 has been announced on Mar 21, 2024. It will be paid May 1, 2024 with an ex-dividend date of Apr 19, 2024. | Neutral | |
| 2024-01-19 04:44 EST | Dividend | A dividend of $0.67 has been announced on Dec 5, 2023. It will be paid Feb 1, 2024 with an ex-dividend date of Jan 19, 2024. | Neutral | |
| 2023-10-19 05:43 EST | Dividend | A dividend of $0.61 has been announced on Sep 21, 2023. It will be paid Nov 1, 2023 with an ex-dividend date of Oct 19, 2023. | Neutral | |
| 2023-07-20 05:43 EST | Dividend | A dividend of $0.61 has been announced on Jul 7, 2023. It will be paid Aug 1, 2023 with an ex-dividend date of Jul 20, 2023. | Neutral | |
About CVS Health Corporation (CVS):
CVS Health Corporation provides health services in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail order, mail order dispensing, and compounding pharmacies, as well as b read more...ranches for infusion and enteral nutrition services. Its Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. As of December 31, 2020, it operated approximately 9,900 retail locations and 1,100 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
General
- Name CVS Health Corporation
- Symbol CVS
- Type Common Stock
- Exchange NYSE
- Currency USD
- Country USA
- SectorHealthcare
- IndustryHealthcare Plans
- Full Time Employees 213,000
- Last Split Factor2:1
- Last Split Date2005-06-07
- Fiscal Year EndDecember
- IPO Date1984-12-17
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Providers & Services
- Gic SubIndustryHealth Care Services
- Web URLhttp://www.cvshealth.com
Valuation
- Trailing PE 13.63
- Forward PE 9.84
- Price/Sales (Trailing 12 Mt.) 0.36
- Price/Book (Most Recent Quarter) 1.4
- Enterprise Value Revenue 0.64
- Enterprise Value EBITDA 10
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $7.50
- Next Year EPS Estimate $8.11
- Next Quarter EPS Estimate $1.84
- Profit Margin 3%
- Operating Margin 5%
- Return on Assets 4%
- Return on Equity 11%
- Revenue 267.91 billion
- Earnings Per Share $5.46
- Revenue Per Share $204.67
- Gross Profit 48.25 billion
- Quarterly Earnings Growth 3.9%
ESG Rating
Highlights
- Market Capitalization 97.67 billion
- EBITDA 18.1 billion
- PE Ratio 10.01
- PEG Ratio 1.56
- Analyst Target Price $86.05
- Book Value Per Share $52.97
Share Statistics
- Shares Outstanding 1.31 billion
- Shares Float 1.31 billion
- % Held by Insiders 17%
- % Held by Institutions 78%
- Shares Short 18.6 million
- Shares Short Prior Month 15.54 million
- Short Ratio 2.6
- Short % of Float 1%
- Short % of Shares Outstanding 1%
Technicals
- Beta 0.81
- 52 Week High $77.23
- 52 Week Low $50.44
- 50 Day Moving Average 71.79
- 200 Day Moving Average 66.81
Dividends
- Forward Annual Dividend Rate $2
- Forward Annual Dividend Yield 2.7%
- Payout Ratio 27%
- Dividend Date 2021-05-03
- ExDividend Date 2021-04-22
- Dividend Per Share $2
- Dividend Yield 4.47%
CVS Health Corporation (CVS) Dividend Calendar:
CVS Health Corporation pays an annual dividend of $2 per share, with a dividend yield of 4.47%.
CVS's last dividend payment was made to shareholders on May 3, 2021.
CVS Health Corporation pays out 27% of its earnings out as a dividend.
CVS Health Corporation (CVS) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
CVS Health Corporation (CVS) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
CVS Health Corporation (CVS) Chart:
CVS Health Corporation (CVS) News:
Below you will find a list of latest news for CVS Health Corporation (CVS) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
CVS Health Corporation (CVS) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Latest CVS Trades:
CVS Health Corporation (CVS) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | View |
|---|---|---|
| 2020-11-06 | 8-K (Current report) | |
| 2020-11-06 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-11-06 | 8-K (Current report) | |
| 2020-09-25 | 8-K (Current report) | |
| 2020-09-15 | 8-K (Current report) | |
| 2020-08-26 | 8-K (Current report) | |
| 2020-08-21 | 8-K (Current report) | |
| 2020-08-14 | 424B2 (Prospectus [Rule 424(b)(2)]) | |
| 2020-08-14 | 8-K (Current report) | |
| 2020-08-12 | 8-K (Current report) | |
| 2020-08-12 | 424B3 (Prospectus [Rule 424(b)(3)]) | |
| 2020-08-12 | FWP (Filing under Securities Act Rules 163/433 of free writing prospectuses) | |
| 2020-08-05 | 8-K (Current report) | |
| 2020-08-05 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-07-10 | 8-K (Current report) | |
| 2020-06-23 | 11-K (Annual report of employee stock purchase, savings and similar plans) | |
| 2020-06-23 | 11-K (Annual report of employee stock purchase, savings and similar plans) | |
| 2020-06-23 | 11-K (Annual report of employee stock purchase, savings and similar plans) | |
| 2020-06-10 | 8-K (Current report) | |
| 2020-05-28 | 4 (Statement of changes in beneficial ownership of securities) | |
CVS Health Corporation (CVS) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of CVS Health Corporation (CVS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 17%
Institutional Ownership: 7800%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-05-26 | James David Clark | SVP, Cont & Chief Acct Officer | Sell | 270.00 | 65.00 | 17,550.00 | 4,547.26 | |
| 2020-05-26 | Jonathan E. Mayhew | EVP - Transformation | Sell | 10,556.00 | 65.00 | 686,140.00 | 4,732.00 | |
| 2020-05-14 | C DAVID II BROWN | Director | Buy | 1,986.00 | 62.31 | 123,747.66 | 117,255.00 | |
| 2020-05-14 | DAVID W DORMAN | Director | Buy | 4,694.00 | 62.31 | 292,483.14 | 136,492.00 | |
| 2020-05-14 | JEAN PIERRE MILLON | Director | Buy | 1,865.00 | 62.31 | 116,208.15 | 1,865.00 | |
| 2020-05-14 | NANCY ANN DEPARLE | Director | Buy | 1,955.00 | 62.31 | 121,816.05 | 18,764.00 | |
| 2020-05-14 | FERNANDO AGUIRRE | Director | Buy | 1,865.00 | 62.31 | 116,208.15 | 21,860.00 | |
| 2020-05-14 | TONY L WHITE | Director | Buy | 1,955.00 | 62.31 | 121,816.05 | 33,218.00 | |
| 2020-05-14 | MARY L SCHAPIRO | Director | Buy | 2,487.00 | 62.31 | 154,964.97 | 4,373.00 | |
| 2020-05-11 | Alan Lotvin | EVP and President-CVS Caremark | Buy | 5,000.00 | 63.14 | 315,675.00 | 15,161.33 | |
| 2020-04-28 | James David Clark | SVP, Cont & Chief Acct Officer | Sell | 6,234.00 | 65.00 | 405,210.00 | 4,817.26 | |
| 2020-04-01 | James David Clark | SVP, Cont & Chief Acct Officer | Buy | 7,713.00 | 58.34 | 449,976.42 | 20,204.00 | |
| 2020-03-30 | James David Clark | SVP, Cont & Chief Acct Officer | Buy | 3,030.00 | 54.53 | 165,225.90 | 12,790.26 | |
| 2020-03-30 | James David Clark | SVP, Cont & Chief Acct Officer | Sell | 3,030.00 | 60.00 | 181,800.00 | 9,760.26 | |
| 2020-02-28 | Troyen A Brennan | EVP and Chief Medical Officer | Buy | 25,346.00 | 59.18 | 1,499,976.28 | 109,663.06 | |
| 2020-02-28 | Joshua Matthew Flum | EVP, ENT STRATEGY & DIGITAL | Buy | 1.00 | 59.18 | 59.18 | 13,691.00 | |
| 2020-02-28 | James David Clark | SVP, Cont & Chief Acct Officer | Buy | 1,912.00 | 59.18 | 113,152.16 | 14,733.00 | |
| 2020-02-28 | Joshua Matthew Flum | EVP, ENT STRATEGY & DIGITAL | Buy | 3,379.00 | 59.18 | 199,969.22 | 24,853.96 | |
| 2020-02-28 | Alan Lotvin | EVP, Transformation | Buy | 11,828.00 | 59.18 | 699,981.04 | 27,945.09 | |
| 2020-02-28 | Jonathan C Roberts | EVP & Chief Operating Officer | Buy | 63,366.00 | 59.18 | 3,749,999.88 | 295,406.06 | |